Sepsis Diagnostics Market is Anticipated To Maintain Its Lead Over The Forecast Period

 Sepsis Diagnostics Industry Overview

The global sepsis diagnostics market size was valued at USD 615.4 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.6% from 2022 to 2030. Factors, such as the high prevalence of sepsis, increasing awareness, and the introduction of technologically advanced diagnostic solutions are expected to significantly fuel the market growth over the forecast period. Sepsis is a severe medical condition caused by the overwhelming immune response to an infection. Recent studies have shown an increasing prevalence of this life-threatening disease around the globe.

According to the data published by the WHO in April 2018, globally, this condition affects more than 30 million people and leads to around 6 million deaths every year. The same source states that globally, around 3 million newborns and 1.2 million children suffer from this condition every year. Such a high prevalence is anticipated to increase demand for its diagnostic solutions, thus fueling the market growth over the forecast period. The outbreak of novel coronavirus (COVID-19) and a subsequent increase in the risk of developing sepsis are some of the key contributors driving the demand for diagnostics solutions.

Gather more insights about the market drivers, restrains and growth of the Global Sepsis Diagnostics market

 

According to the Global Sepsis Alliance in April 2020, around 30% of COVID-19 patients had evidence of liver injury and around 75% reported a depressed immune response in Seattle, U.S. Accord. As per the Global Sepsis Alliance, viruses responsible for COVID-19, influenza, pneumonia, meningitis, and others are primarily responsible for causing sepsis. Based on a retrospective study, hospitalized COVID-19 patients pose a higher risk of developing coinfections. The study revealed that among the non-survivors, around 50% of patients had a secondary infection, almost 100% of the non-survivors had sepsis, and about 70% had septic shock.

Thus, one of the critical causes of mortality among COVID-19 patients is sepsis. Currently, most of the existing diagnostic tests can take up to 72 hours to process and provide final results. Thus, high demand for rapid diagnostic tests exists in the market for the early diagnosis of sepsis that could save thousands of lives. In February 2019, researchers at the University of Strathclyde discovered a ground-breaking and cost-effective test for earlier diagnosis of this disease. This newly developed test uses a microelectrode to analyze the patients’ blood and can provide final results in around two and a half minutes.

Key players in the market have lucrative opportunities to strengthen their market position with the development and launch of such advanced rapid tests. Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions are expected to be the prominent factors facilitating market growth over the forecast period. For instance, in May 2020, Beckman Coulter launched its new DxH 690T hematology analyzer with early sepsis indicators in the U.S. In August 2018, Japan-based Sysmex Corp. launched its new HISCL Presepsin Assay Kit for determining levels of presepsin, the main test parameter for bacterial sepsis.

This kit is designed to achieve early diagnosis of bacterial sepsis with high precision as compared to conventional biomarkers. Hospital-Acquired Infections (HAIs) can trigger sepsis, especially in the geriatric population, newborn babies, and people suffering from chronic diseases. The prevalence of HAIs is increasing owing to the high incidence of various chronic diseases, such as diabetes. A rise in the number of admissions in acute care hospitals often leads to infections, which cause sepsis. Sepsis, in such a group of patients, sometimes leads to re-hospitalization within 30 days of treatment, which propels the demand for its diagnostic products in hospitals.

Hospital-acquired infections majorly include Urinary Tract Infections (UTIs) and Surgical-Site Infections (SSIs), which can result in sepsis. According to the WHO, 7 out of every 100 hospitalized patients are likely to develop HAIs in developed countries, whereas this number is likely to increase to 10 in developing countries due to poor healthcare infrastructure. In addition, according to the CDC estimates, every year, around 1.7 million patients suffer from HAIs and around 99,000 patients die due to HAIs in the U.S.


Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Digital Stethoscope Market - Digital Stethoscope is evolving at a faster rate and is considered an instrument that helps in amplifying the low sound level. These are mainly used in general medicine, cardiology, telemedicine, veterinary, and pediatrics. Artificial intelligence technology is used in digital stethoscopes which assists in analysing the algorithm of the detected heart sounds.
  •  
  • Wellness Tourism Market - The global wellness tourism market size was valued at USD 814.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.42% from 2023 to 2030. Wellness tourism refers to tourism activities aimed at improving and enhancing an individual's physical, mental, and spiritual well-being.


Sepsis Diagnostics Market Segmentation

Grand View Research has segmented the global sepsis diagnostics market based on product, technology, pathogen, testing type, end-user, method and region:

Sepsis Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Instruments
  • Blood Culture Media
  • Assay Kits & Reagents

Sepsis Diagnostics Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Others

Sepsis Diagnostics Pathogen Outlook (Revenue, USD Million, 2018 - 2030)

  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Others

Sepsis Diagnostics Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Laboratory Testing
  • POC Testing

Sepsis Diagnostics Method Outlook (Revenue, USD Million, 2018 - 2030)

  • Automated Diagnostics
  • Conventional Diagnostics

Sepsis Diagnostics End-user Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals & Clinics
  • Pathology & Reference Laboratories
  • Research Institutes and Others

Sepsis Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)


Market Share Insights

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • January 2020: Roche and Inotrem SA, a France-based company, formed a strategic agreement for the commercialization of a companion diagnostics test intended for septic shock.

 

  • May 2020: the Biomedical Advanced Research and Development Authority (BARDA) collaborated with Beckman Coulter for the development of a digital algorithm to identify sepsis in patients with COVID-19.

 

Key Companies profiled:

Some of the prominent players in the global sepsis diagnostics market include:

  • bioMérieux SA
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Hoffmann-La Roche AG
  • Danaher Corporation (Beckman Coulter, Inc.)
    • Cepheid
    • Beckman Coulter, Inc.
  • Luminex Corp.
  • Bruker Corp.
  • Amara Health Analytics
  • Wolters Kluwer N.V.
  • Cerner Corp.
  • Epic Systems Corp.
  • Mckesson Corp.
  • GE Healthcare
  • Koninklijke Philips N.V.

 

Order a free sample PDF of the Sepsis Diagnostics Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more